‘A Divorce But We Weren’t Even Married’ – Swiss Medtech Expects No EU MRA Before May
EU grace period might be allowed for Swiss devices in April
A last-minute solution to the unresolved EU MRA issue is unlikely, so local manufacturers must prepare for Switzerland to be a “third country” to the EU after the MDR comes fully into force.
You may also be interested in...
Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.
Patient care and device trade will suffer without urgent attention to the signing of the EU-Switzerland medtech mutual recognition agreement, say German health care products groups.
The trend among device innovators to focus on diagnostic technologies that improve imaging, offer better visualization of tissues and avoid the need for biopsies is well noted by full-service law firm CMS. Its equIP program supports many start-ups incorporating AI into products and development processes.